$OCGN I neglected to read Bharat's response to AIIMS trial and their attachment thoroughly. Thought they were just rolling over and accepting the AIIMS trial 50% assessment, based on their two line comment (and strange wording) above attachment. The attachment wording qualifying the AIIMS results is really very strong if you read down. Hope others didn't make same mistake as I. twitter.com/bharatbiotech/s...
1
5
5 Likes